Bernd Wollscheid Selected Research

Bernd Wollscheid Research Topics

Disease

15	Neoplasms (Cancer) 04/2022 - 02/2004
3	Malignant Mesothelioma 01/2021 - 12/2012
3	Colonic Neoplasms (Colon Cancer) 01/2016 - 03/2014
3	Leukemia 11/2014 - 09/2010
2	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 07/2014
2	Coronary Disease (Coronary Heart Disease) 11/2021 - 01/2020
2	Fatty Liver 05/2020 - 01/2018
2	Starvation 01/2020 - 01/2013
2	Infections 01/2018 - 01/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2014 - 06/2013
1	Type 2 Diabetes Mellitus (MODY) 11/2021
1	Mesothelioma 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Nervous System Diseases (Neurological Disorders) 09/2019
1	Neurodevelopmental Disorders 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Glioma (Gliomas) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Lymphoma (Lymphomas) 08/2015
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2015
1	Hypoxia (Hypoxemia) 03/2015
1	Neoplasm Metastasis (Metastasis) 07/2014
1	Obesity 07/2013
1	Body Weight (Weight, Body) 07/2013
1	Carcinogenesis 12/2012
1	Glioblastoma (Glioblastoma Multiforme) 10/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2012
1	Congenital Structural Myopathies (Centronuclear Myopathy) 05/2012
1	Adenocarcinoma of Lung 02/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2010

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 04/2022 - 02/2004
6	Glycoproteins (Glycoprotein)IBA 07/2014 - 06/2012
5	ProteomeIBA 11/2021 - 09/2010
5	Membrane Proteins (Integral Membrane Proteins)IBA 08/2015 - 09/2010
4	Biomarkers (Surrogate Marker)IBA 04/2022 - 06/2012
4	Pharmaceutical PreparationsIBA 09/2019 - 09/2010
3	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2015 - 10/2012
2	Biological ProductsIBA 01/2021 - 06/2012
2	LipidsIBA 01/2020 - 01/2018
2	AntibodiesIBA 01/2018 - 10/2012
2	Triglycerides (Triacylglycerol)IBA 01/2018 - 07/2013
2	sulforaphaneIBA 01/2016 - 03/2014
2	GlycopeptidesIBA 07/2014 - 11/2013
1	VitronectinIBA 04/2022
1	Complement System Proteins (Complement)IBA 04/2022
1	GoldIBA 04/2022
1	Fibronectins (Fibronectin)IBA 04/2022
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 11/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	thiaclopridIBA 05/2020
1	clothianidinIBA 05/2020
1	enilconazole (imazalil)IBA 05/2020
1	apolipoprotein FIBA 01/2020
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 01/2020
1	phospholipase D1IBA 01/2020
1	sphingadienineIBA 01/2020
1	SphingomyelinsIBA 01/2020
1	Bacterial ToxinsIBA 09/2019
1	incobotulinumtoxinA FDA Link 09/2019
1	Type A Botulinum Toxins (Botox)FDA Link 09/2019
1	Messenger RNA (mRNA)IBA 11/2018
1	PeptidomimeticsIBA 01/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018
1	cyproconazoleIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	LigandsIBA 01/2018
1	teleocalcinIBA 01/2018
1	histidine-rich proteinsIBA 01/2018
1	murepavadinIBA 01/2018
1	ProdrugsIBA 01/2016
1	EnzymesIBA 01/2016
1	PR-104AIBA 01/2016
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2015
1	carbonic anhydrase XIIIBA 03/2015
1	Transcription Factors (Transcription Factor)IBA 03/2015
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2015
1	Protein Kinases (Protein Kinase)IBA 01/2015
1	tyrosine receptor (receptor, tyrosine)IBA 01/2015
1	Cysteine (L-Cysteine)FDA Link 11/2014
1	Cysteine Dioxygenase (Dioxygenase, Cysteine)IBA 11/2014
1	amidaseIBA 07/2014
1	AcidsIBA 07/2014
1	N-acylethanolaminesIBA 07/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 07/2014
1	Aldo-Keto ReductasesIBA 03/2014
1	3-hydroxycholest-7-ene-14-carbaldehydeIBA 03/2014
1	SeleniumIBA 03/2014
1	AdiponectinIBA 07/2013
1	SphingolipidsIBA 01/2013
1	GlycosphingolipidsIBA 01/2013
1	IntegrinsIBA 01/2013
1	Dynamin IIIBA 05/2012
1	ClathrinIBA 05/2012
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2010

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 03/2015
1	Prostatectomy (Retropubic Prostatectomy) 04/2022
1	Precision Medicine 01/2021
1	Therapeutics 01/2016
1	Aftercare (After-Treatment) 03/2014